@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-ACES_SU-AS000250 a mbo:MassSpectrum ;
    dcterms:creator "ACESx, Jonathan W. Martin Group" ;
    dcterms:date "2022-08-15"^^xsd:date ;
    dcterms:identifier "MSBNK-ACES_SU-AS000250" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights "Stockholm University, ACESx, Jonathan W. Martin Group (C) 2022 under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "QExactive Orbitrap HF-X (Thermo Scientific)" ;
            mbo:collision_energy "Ramp 20%-70% (nominal)" ;
            mbo:column_name "Waters; Acquity UPLC BEH C18, 2.1 x 100 mm, 1.7 um, Waters" ;
            mbo:flow_gradient "98/2 at 4.2 min, 0/100 at 22 min, 0/100 at 25 min, 98/2 at 25.1 min, 98/2 at 30 min" ;
            mbo:flow_rate "0.45mL/min" ;
            mbo:fragmentation_mode "HCD" ;
            mbo:instrument_type "LC-ESI-QFT" ;
            mbo:ion_mode "NEGATIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "30000" ;
            mbo:retention_time "14.824000" ;
            mbo:solvent "A 1 mM ammonium fluoride in water",
                "B MeOH" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "Losartan",
                "[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol" ;
            mbo:ch_compound_class "Drugs; Angiotensin II Receptor Antagonists; Benzene Derivatives; Biphenyl Compounds" ;
            mbo:ch_exact_mass 4.221622e+02 ;
            schema:inChI "InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)" ;
            schema:molecularFormula "C22H23ClN6O" ;
            schema:name "Losartan",
                "[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol" ;
            schema:smiles "ClC=1N=C(N(C1CO)CC2=CC=C(C=C2)C3=CC=CC=C3C=4N=NNN4)CCCC" ] ;
    mbo:has_peak [ mbo:intensity 1.17801e+07 ;
            mbo:mz 1.139994e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 45 ],
        [ mbo:intensity 3.970563e+06 ;
            mbo:mz 2.111596e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 15 ],
        [ mbo:intensity 3.481847e+06 ;
            mbo:mz 2.72144e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 13 ],
        [ mbo:intensity 2.808346e+07 ;
            mbo:mz 3.351312e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 107 ],
        [ mbo:intensity 9.110784e+06 ;
            mbo:mz 3.631399e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 35 ],
        [ mbo:intensity 6.361468e+06 ;
            mbo:mz 3.931503e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 24 ],
        [ mbo:intensity 2.618975e+08 ;
            mbo:mz 4.211566e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 7.429478e+07 ;
            mbo:mz 1.270071e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 283 ],
        [ mbo:intensity 1.594829e+07 ;
            mbo:mz 1.550383e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 61 ],
        [ mbo:intensity 3.432279e+06 ;
            mbo:mz 1.560461e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 13 ],
        [ mbo:intensity 3.240781e+07 ;
            mbo:mz 1.570541e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 124 ],
        [ mbo:intensity 2.875802e+07 ;
            mbo:mz 1.790868e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 110 ],
        [ mbo:intensity 2.374682e+07 ;
            mbo:mz 1.870643e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 91 ],
        [ mbo:intensity 4.174135e+06 ;
            mbo:mz 1.880362e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 16 ],
        [ mbo:intensity 5.791981e+06 ;
            mbo:mz 1.950814e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 22 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 4.211566e+02 ;
            mbo:precursor_mz 4.211558e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 15 ;
    mbo:pk_splash "splash10-00di-0601900000-eb85e38aa32f958164a8" ;
    rdfs:comment "CONFIDENCE Standard Compound (Level 1)" ;
    skos:definition "Losartan; LC-ESI-QFT; MS2; CE: Ramp 20%-70% (nominal); R=30000; [M-H]-" .

